Debpali Sur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Debpali Sur has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Albert Pinhasov
Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel 4070000, Israel
1 shared publication - Anastasia Bagaev
Institute of Personalized and Translational Medicine, Ariel University, Ariel 40700, Israel
1 shared publication - Andy Boiangiu
Institute of Personalized and Translational Medicine, Ariel University, Ariel 40700, Israel
1 shared publication - Anita Mahadevan
Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bengaluru, India
1 shared publication - Beatriz G. S. Rocha
Institute of Personalized and Translational Medicine, Ariel University, Ariel 40700, Israel
1 shared publication - Dilorom Begmatova
Institute of Personalized and Translational Medicine, Ariel University, Ariel 40700, Israel
1 shared publication
Latest Publications
- Open Access
- 15 September 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (9) , 1463
Prenatal THC Exposure Differentially Alters Gut Physiology and Microbiota in Stress-Resilient and Vulnerable Mice
Background/Objectives: Prenatal environmental exposures can shape neurodevelopmental outcomes through the gut–brain axis. The endocannabinoid system contributes to both neurodevelopment and gastrointestinal homeostasis and may, therefore, be vulnerable to disruption by exogenous cannabinoids such as Δ9-tetrahydrocannabinol (THC). Using established dominant (Dom; stress-resilient) and submissive (Sub; stress-vulnerable) mouse lines, this study examined whether prenatal THC exposure (PTE) produces phenotype-dependent alterations in gut physiology, colonic endocannabinoid- and inflammation-related gene expression, and gut microbiota composition. Methods: Pregnant Dom and Sub mice received vehicle or THC during gestation. Maternal stool samples were analyzed after exposure, and offspring were assessed at postnatal day 30. Gut and colon lengths were measured; colonic mRNA expression of selected endocannabinoid-, barrier-, and inflammation-related genes was quantified by qRT-PCR; and gut microbiota composition was analyzed using 16S rRNA sequencing with diversity and differential-abundance analyses. Results: PTE induced phenotype-dependent alterations in maternal gut microbiota. Sub dams exhibited enrichment of taxa associated with inflammatory states and depletion of Bacteroides and Parabacteroides, whereas Dom dams showed no significant taxonomic shifts. In offspring, Sub mice showed shorter baseline gut and colon lengths than Dom mice. PTE reduced gut and colon length in Dom offspring but not in Sub offspring. PTE also increased colonic CB1R expression in Dom offspring and reduced PPARγ expression in Sub offspring. Microbiota analysis revealed bidirectional phenotype-dependent remodeling, including increased Lachnospiraceae-related taxa and reduced Ligilactobacillus in Dom offspring, with an opposite pattern in Sub offspring. Conclusions: PTE produces phenotype-dependent effects on gut physiology, colonic gene expression, and microbiota composition. These findings identify the host stress-coping phenotype as a potential modifier of developmental responses to prenatal THC but do not establish causal relationships among microbiota, intestinal outcomes, and previously reported behavioral effects.
- 15 September 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (9) , 1463
Open AccessPrenatal THC Exposure Differentially Alters Gut Physiology and Microbiota in Stress-Resilient and Vulnerable Mice
Background/Objectives: Prenatal environmental exposures can shape neurodevelopmental outcomes through the gut–brain axis. The endocannabinoid system contributes to both neurodevelopment and gastrointestinal homeostasis and may, therefore, be vulnerable to disruption by exogenous cannabinoids such as Δ9-tetrahydrocannabinol (THC). Using established dominant (Dom; stress-resilient) and submissive (Sub; stress-vulnerable) mouse lines, this study examined whether prenatal THC exposure (PTE) produces phenotype-dependent alterations in gut physiology, colonic endocannabinoid- and inflammation-related gene expression, and gut microbiota composition. Methods: Pregnant Dom and Sub mice received vehicle or THC during gestation. Maternal stool samples were analyzed after exposure, and offspring were assessed at postnatal day 30. Gut and colon lengths were measured; colonic mRNA expression of selected endocannabinoid-, barrier-, and inflammation-related genes was quantified by qRT-PCR; and gut microbiota composition was analyzed using 16S rRNA sequencing with diversity and differential-abundance analyses. Results: PTE induced phenotype-dependent alterations in maternal gut microbiota. Sub dams exhibited enrichment of taxa associated with inflammatory states and depletion of Bacteroides and Parabacteroides, whereas Dom dams showed no significant taxonomic shifts. In offspring, Sub mice showed shorter baseline gut and colon lengths than Dom mice. PTE reduced gut and colon length in Dom offspring but not in Sub offspring. PTE also increased colonic CB1R expression in Dom offspring and reduced PPARγ expression in Sub offspring. Microbiota analysis revealed bidirectional phenotype-dependent remodeling, including increased Lachnospiraceae-related taxa and reduced Ligilactobacillus in Dom offspring, with an opposite pattern in Sub offspring. Conclusions: PTE produces phenotype-dependent effects on gut physiology, colonic gene expression, and microbiota composition. These findings identify the host stress-coping phenotype as a potential modifier of developmental responses to prenatal THC but do not establish causal relationships among microbiota, intestinal outcomes, and previously reported behavioral effects.
- Open Access
- 22 November 2017
- Published by Springer Nature in Mobile DNA
- Vol. 8 (1) , 1-12
Detection of the LINE-1 retrotransposon RNA-binding protein ORF1p in different anatomical regions of the human brain
Recent reports indicate that retrotransposons – a type of mobile DNA – can contribute to neuronal genetic diversity in mammals. Retrotransposons are genetic elements that mobilize via an RNA intermediate by a “copy-and-paste” mechanism termed retrotransposition. Long Interspersed Element-1 (LINE-1 or L1) is the only active autonomous retrotransposon in humans and its activity is responsible for ~ 30% of genomic mass. Historically, L1 retrotransposition was thought to be restricted to the germline; however, new data indicate L1 s are active in somatic tissue with certain regions of the brain being highly permissive. The functional implications of L1 insertional activity in the brain and how host cells regulate it are incomplete. While deep sequencing and qPCR analysis have shown that L1 copy number is much higher in certain parts of the human brain, direct in vivo studies regarding detection of L1-encoded proteins is lacking due to ineffective reagents. Using a polyclonal antibody we generated against the RNA-binding (RRM) domain of L1 ORF1p, we observe widespread ORF1p expression in post-mortem human brain samples including the hippocampus which has known elevated rates of retrotransposition. In addition, we find that two brains from different individuals of different ages display very different expression of ORF1p, especially in the frontal cortex. We hypothesize that discordance of ORF1p expression in parts of the brain reported to display elevated levels of retrotransposition may suggest the existence of factors mediating post-translational regulation of L1 activity in the human brain. Furthermore, this antibody reagent will be useful as a complementary means to confirm findings related to retrotransposon biology and activity in the brain and other tissues in vivo.
- 22 November 2017
- Published by Springer Nature in Mobile DNA
- Vol. 8 (1) , 1-12
Open AccessDetection of the LINE-1 retrotransposon RNA-binding protein ORF1p in different anatomical regions of the human brain
Recent reports indicate that retrotransposons – a type of mobile DNA – can contribute to neuronal genetic diversity in mammals. Retrotransposons are genetic elements that mobilize via an RNA intermediate by a “copy-and-paste” mechanism termed retrotransposition. Long Interspersed Element-1 (LINE-1 or L1) is the only active autonomous retrotransposon in humans and its activity is responsible for ~ 30% of genomic mass. Historically, L1 retrotransposition was thought to be restricted to the germline; however, new data indicate L1 s are active in somatic tissue with certain regions of the brain being highly permissive. The functional implications of L1 insertional activity in the brain and how host cells regulate it are incomplete. While deep sequencing and qPCR analysis have shown that L1 copy number is much higher in certain parts of the human brain, direct in vivo studies regarding detection of L1-encoded proteins is lacking due to ineffective reagents. Using a polyclonal antibody we generated against the RNA-binding (RRM) domain of L1 ORF1p, we observe widespread ORF1p expression in post-mortem human brain samples including the hippocampus which has known elevated rates of retrotransposition. In addition, we find that two brains from different individuals of different ages display very different expression of ORF1p, especially in the frontal cortex. We hypothesize that discordance of ORF1p expression in parts of the brain reported to display elevated levels of retrotransposition may suggest the existence of factors mediating post-translational regulation of L1 activity in the human brain. Furthermore, this antibody reagent will be useful as a complementary means to confirm findings related to retrotransposon biology and activity in the brain and other tissues in vivo.